Dulogablin-NT Tablet
Marketer
ABS Pharmaceutical Company
Salt Composition
Pregabalin (75mg) + Nortriptyline (10mg)
Overview Dulogablin-NT Tablet
Neuropathic pain is treated with the combined medication, Dulogablin-NT Tablet. This medication reduces pain by interrupting the transmission of pain signals to the brain. Administered orally, Dulogablin-NT Tablets can be taken with or without food, ideally before sleep, at the same time daily for consistent blood levels. Follow your doctor's prescribed dosage and duration precisely, as this medication can be habit-forming. If a dose is missed, take it immediately upon recall. Complete the entire course of treatment, even if symptoms improve. Never discontinue this medication abruptly without consulting your physician. Common side effects include constipation, urinary difficulty, weight gain, fatigue, and dry mouth. Dizziness and drowsiness may also occur, so avoid driving or mentally demanding activities until the effects are known. Weight gain is possible; mitigate this with regular exercise and a balanced diet. Report any unusual mood or behavioral shifts, new or worsening depression, or suicidal ideation to your doctor immediately. Before starting this medication, disclose any kidney or liver conditions, and provide a complete list of all other medications you are taking, as interactions may reduce effectiveness or alter its function. Inform your doctor if you are pregnant, planning pregnancy, or breastfeeding.
Uses of Dulogablin-NT Tablet
Managing neuropathic pain
Major Benefits of Dulogablin-NT Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Swallow the Dulogablin-NT Tablet whole; avoid crushing, chewing, or breaking it. This medication can be taken with or without food, although consistent timing is recommended.
Common Side effects of Dulogablin-NT Tablet:
- Dryness in mouth
- Increased heart rate
- Sleepiness
- Dizziness
- Tiredness
- Weight gain
- Blurred vision
- Orthostatic hypotension (sudden lowering of blood pressure on standing)
- Uncoordinated body movements
- Increased appetite
- Increased libido
- Paresthesia (tingling or pricking sensation)
- Vertigo
- Vomiting
- Nausea
- Erectile dysfunction
- Joint pain
- Constipation
- Difficulty in urination
How to use Dulogablin-NT Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for Dulogablin-NT Tablets. Swallow the tablet whole; avoid chewing, crushing, or breaking it. While Dulogablin-NT Tablets can be administered with or without food, consistent timing is recommended.
How Dulogablin-NT Tablet works:
Dulogablin-NT tablets contain pregabalin and nortriptyline, working synergistically to alleviate neuropathic pain. Pregabalin, an alpha-2-delta ligand, reduces pain transmission by modulating calcium channel function in nerve cells. Nortriptyline, a tricyclic antidepressant, elevates serotonin and noradrenaline levels, thus inhibiting pain signal propagation within the central nervous system. This combined action provides effective relief from nerve damage-related pain.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Dulogablin-NT tablets and alcohol may result in pronounced sleepiness.
PregnancyCONSULT YOUR DOCTOR
Using Dulogablin-NT tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the unborn child. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Dulogablin-NT Tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Driving ability may be impaired by Dulogablin-NT Tablet side effects, due to potential drowsiness induced by the medication.
KidneyCAUTION
Exercise caution when administering Dulogablin-NT Tablets to individuals with impaired renal function. Dosage modifications for Dulogablin-NT Tablets may be necessary; physician consultation is advised.
LiverSAFE IF PRESCRIBED
The use of Dulogablin-NT Tablets in patients with hepatic impairment is likely safe. Preliminary evidence indicates that dose modification may not be necessary. Physician consultation is recommended.
What if you forget to take Dulogablin-NT Tablet :
Should you forget a Dulogablin-NT Tablet dose, administer it immediately. However, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Dulogablin-NT Tablet
| Label | Value |
|---|---|
| Addictive | None. |
| Type of Medication | Central and Peripheral Nervous System |
FAQs on Dulogablin-NT Tablet
Pregabalin and Nortriptyline, combined as Dulogablin-NT Tablet, provide relief from neuropathic pain. The medication's mechanism involves central nervous system modulation, quieting hyperexcitable or injured nerves and consequently reducing pain perception.
Discontinuing Dulogablin-NT Tablet prematurely, even with pain relief, is inadvisable. Follow your physician's prescribed regimen. Abrupt cessation may induce withdrawal effects including anxiety, insomnia, nausea, pain recurrence, and diaphoresis. A gradual dose reduction is recommended prior to complete discontinuation.
Taking Dulogablin-NT Tablets may increase appetite, potentially leading to weight gain. Preventing weight gain is simpler than subsequent weight loss. Maintain a balanced diet without enlarging portion sizes. Limit high-calorie foods like sugary drinks, fried foods, processed snacks, and desserts. Between meals, opt for fruits, vegetables, and low-calorie options instead of unhealthy snacks. Regular physical activity helps prevent weight gain. Consistent healthy eating and exercise may preclude weight increase.
Drowsiness and sudden sleep onset are potential side effects of Dulogablin-NT Tablets. These episodes may occur without warning. Refrain from driving, operating equipment, working at heights, or engaging in hazardous activities, particularly at the treatment's outset, until the medication's effects are understood. Report any such incidents to your physician.
Taking Dulogablin-NT Tablets may impact sexual function in both males and females. Reported issues include reduced libido, difficulties achieving or sustaining an erection (erectile dysfunction), and anorgasmia. Decreased sexual satisfaction and discomfort during intercourse may also occur. Patients experiencing these side effects should consult their physician but should not discontinue Dulogablin-NT Tablet use without medical advice.
Rarely, Dulogablin-NT Tablet can cause serious adverse reactions. Seek immediate medical advice if you experience: altered body temperature, respiratory distress, rapid heartbeat, fatigue, gait instability, impaired coordination or slowed reflexes, unusual mood or behavioral shifts (including agitation, anxiety, or elation), depressive symptoms, hallucinations, disordered thinking, visual disturbances (blurred or double vision), involuntary eye movements, visual impairment, or signs of recurrent infections like fever, intense chills, pharyngitis, or oral ulcers. While infrequent, these reactions necessitate prompt medical intervention.
Patients may experience initial improvements with Dulogablin-NT Tablets within two weeks, although complete therapeutic effects typically manifest within two to three months. In certain individuals, achieving optimal results may require a longer treatment period.
Should you miss a scheduled dose of Dulogablin-NT Tablet, and your next dose is imminent, omit the missed dose and continue with your regular dosing schedule. Conversely, if ample time remains until your next dose, take the missed dose immediately upon remembering, then resume your usual medication regimen. Avoid doubling your dose to compensate for a missed one, as this could lead to adverse reactions from an overdose. When in doubt regarding proper procedure, seek guidance from your physician.
If this occurs, promptly contact your physician or proceed to the closest emergency room. Seek medical assistance regardless of the presence or absence of adverse effects. Immediate treatment may be necessary. Overdose symptoms can manifest as lethargy, debility, gait instability, diplopia, dysarthria, diarrhea, disorientation, visual blurring, vertigo, fluctuating body temperature, respiratory distress, and tachycardia.
Exceeding the prescribed dosage won't necessarily enhance effectiveness; instead, it raises the risk of severe adverse reactions and potential poisoning. Should your symptoms worsen despite adhering to the recommended dose, seek medical advice for reassessment.
Taking Dulogablin-NT Tablets may reduce alertness and impair cognitive function. Exercise caution when operating machinery or engaging in activities demanding concentration. Alcohol consumption should be avoided during treatment with Dulogablin-NT Tablets as it may potentiate the drug's effects, posing a risk. Grapefruit and its juice can interact negatively with this medication, leading to adverse reactions; therefore, their consumption should be avoided. Increased sun sensitivity is a potential side effect of Dulogablin-NT Tablets; therefore, limit sun exposure and utilize protective clothing and sunscreen when outdoors during daylight hours.
Routine checkups with your physician may be necessary following the commencement of Dulogablin-NT Tablet therapy. Consult your doctor immediately if your symptoms persist despite adhering to the prescribed Dulogablin-NT Tablet dosage, or if adverse effects interfere with your daily life.
Retain the tablets in their original packaging until needed. Maintain storage in a cool, dry location. Keep them inaccessible to children. Discard any leftover medication using a designated method to prevent accidental ingestion by children, pets, or others.
Pregabalin and Nortriptyline, combined as Dulogablin-NT Tablets, provide relief from neuropathic pain. The medication works by modulating brain activity, thus soothing the effects of damaged or hyperactive nerves and reducing pain perception.
Discontinuing Dulogablin-NT Tablet prematurely, even with pain relief, is inadvisable. Follow your physician's prescribed regimen. Abrupt cessation may trigger withdrawal effects including anxiety, insomnia, nausea, pain recurrence, and diaphoresis. A gradual dose reduction is typically necessary before complete discontinuation.
Taking Dulogablin-NT Tablets may increase appetite, potentially leading to weight gain. Managing weight gain is simpler than weight loss. Maintain a nutritious, balanced diet without enlarging portions. Limit high-calorie foods like sugary drinks, fried foods, processed snacks, and desserts. Between meals, choose fruits, vegetables, and low-calorie options instead of unhealthy snacks. Regular physical activity helps prevent weight gain. Consistent healthy eating and exercise may prevent any weight increase associated with this medication.
Drowsiness and sudden sleep onset are potential side effects of Dulogablin-NT Tablets. These episodes may occur without warning. Refrain from driving, operating equipment, working at heights, or engaging in hazardous activities, especially initially, until the medication's effects are known. Report any such incidents to your physician.
Taking Dulogablin-NT Tablets may impact sexual function in both genders. Reduced libido, erectile dysfunction (difficulty achieving or sustaining an erection), and anorgasmia are frequently reported. Decreased sexual satisfaction and discomfort during intercourse are also possible side effects. Report any such issues to your physician, but continue taking Dulogablin-NT Tablets unless otherwise instructed.
Rarely, Dulogablin-NT Tablets can cause serious adverse reactions. Seek immediate medical advice if you experience: altered body temperature, respiratory distress, rapid heartbeat, fatigue, gait instability, impaired coordination or slowed reflexes, unusual mood or behavioral shifts (including agitation, anxiety, or elation), depressive symptoms, hallucinations, illogical thought processes, visual disturbances (blurred or double vision), involuntary eye movements, vision impairment, or frequent infections manifested by fever, intense chills, pharyngitis, or oral ulcers. While infrequent, these reactions warrant prompt medical intervention.
Patients may experience initial improvements with Dulogablin-NT Tablet within two weeks, although complete therapeutic effects typically manifest within two to three months. Some individuals may require a longer treatment duration to achieve optimal results.
Should you miss a scheduled Dulogablin-NT Tablet dose, and your next dose is imminent, omit the missed dose and continue with your regular dosing schedule. If your next dose is not soon, take the missed dose immediately upon remembering, then resume your usual medication routine. Avoid doubling your dose to compensate; doing so may heighten the risk of adverse reactions from an overdose. For any uncertainty regarding missed doses, seek guidance from your physician.
If this occurs, promptly contact your physician or proceed to the closest emergency room. This is crucial, regardless of the presence or absence of adverse effects. Immediate medical intervention may be necessary. Overdosage may manifest as lethargy, fatigue, gait instability, diplopia, dysarthria, diarrhea, disorientation, blurred vision, vertigo, fluctuating body temperature, respiratory distress, and tachycardia.
Increasing the prescribed dosage of medication won't necessarily enhance its effectiveness; instead, it could heighten the risk of adverse reactions and harmful side effects. Should your symptoms worsen despite adhering to the recommended dosage, seek medical advice for reassessment.
Taking Dulogablin-NT Tablets might affect your cognitive function and reflexes. Exercise caution when operating machinery or engaging in activities demanding alertness. Alcohol consumption should be avoided while using Dulogablin-NT Tablets as it can intensify the alcohol's effects, posing a risk. Grapefruit and its juice can interact negatively with this medication, potentially leading to adverse reactions. Limit sun exposure and the use of tanning beds. Dulogablin-NT Tablets increase sun sensitivity, raising the risk of sunburn. Protective clothing and sunscreen are recommended during daytime outdoor activities.
Routine checkups with your physician are recommended following the initiation of Dulogablin-NT Tablet treatment. Consult your doctor immediately if your symptoms persist despite adhering to the prescribed Dulogablin-NT Tablet dosage, or if you encounter adverse effects that interfere with your daily life.
Retain the medication within its original packaging until needed. Store in a cool, dry location, inaccessible to children. Dispose of any remaining medicine using appropriate methods to prevent accidental ingestion by children, pets, or others.
Pregabalin and Nortriptyline, combined in Dulogablin-NT Tablets, offer relief from neuropathic pain. The medication works by modulating brain activity to soothe damaged or overly sensitive nerves, thus reducing the perception of pain.
Discontinuing Dulogablin-NT Tablet prematurely, even with pain relief, is inadvisable. Follow your physician's prescribed dosage regimen. Abrupt cessation may trigger withdrawal effects including, but not limited to, anxiety, insomnia, nausea, renewed pain, and diaphoresis. A gradual dose reduction is recommended prior to complete discontinuation.
Taking Dulogablin-NT Tablets may increase appetite, potentially leading to weight gain. Weight management is simpler than weight loss. Maintain a nutritious, balanced diet without enlarging meal portions. Limit high-calorie foods like sugary drinks, fried foods, processed snacks, and desserts. Between meals, choose fruits, vegetables, and low-calorie options instead of unhealthy snacks. Regular physical activity helps prevent weight gain. Consistent healthy eating and exercise may mitigate weight increase.
Drowsiness and sudden sleep onset are potential side effects of Dulogablin-NT Tablets. These episodes may occur without warning. Refrain from operating vehicles, machinery, or engaging in hazardous activities, especially initially, until the medication's effects are understood. Report any such incidents to your physician.
Taking Dulogablin-NT Tablets may impact sexual function in both males and females. Reduced libido, erectile dysfunction (difficulty achieving or sustaining an erection), and anorgasmia are frequently reported. Decreased sexual satisfaction and discomfort during intercourse may also occur. Consult your physician if these issues arise, but continue taking Dulogablin-NT Tablets unless otherwise instructed.
Rarely, Dulogablin-NT Tablets may cause serious adverse reactions. Seek immediate medical advice if you experience: altered body temperature, respiratory distress, rapid heartbeat, fatigue, gait instability, impaired coordination or slowed reflexes, unusual mood or behavioral shifts (including agitation, anxiety, or euphoria), depressive symptoms, hallucinations, illogical thought processes, vision disturbances (blurred or double vision, involuntary eye movements, visual impairment), or recurring infections (manifested by fever, intense chills, sore throat, or oral ulcers). While infrequent, these side effects warrant prompt medical intervention.
Patients may experience initial improvements with Dulogablin-NT Tablets within two weeks, although complete therapeutic effects might not be apparent for two to three months. In certain individuals, achieving full benefit may require a longer treatment duration.
Should you miss a scheduled Dulogablin-NT Tablet dose, and your next dose is imminent, omit the missed dose and proceed with your usual schedule. If, however, sufficient time remains before your next dose, take the medication immediately upon recollection, then resume your regular dosing regimen. Avoid doubling up on doses to compensate for a missed one; this can heighten the likelihood of adverse reactions from an overdose. For any uncertainty, seek guidance from your physician regarding appropriate action.
Urgent medical care is necessary in this instance; contact your physician without delay or proceed to the closest emergency room. This is crucial regardless of the presence or absence of symptoms. Overdose symptoms can manifest as lethargy, debility, gait instability, diplopia, dysarthria, diarrhea, disorientation, blurred vision, vertigo, fluctuating body temperature, respiratory distress, and tachycardia.
Exceeding the prescribed dosage won't necessarily improve outcomes; in fact, it heightens the risk of severe adverse reactions and potential poisoning. Should your symptoms worsen despite adhering to the recommended dosage, seek medical advice for reassessment.
Taking Dulogablin-NT Tablets may affect cognitive function and response times. Exercise caution when operating machinery or engaging in activities demanding alertness. Alcohol consumption should be avoided during treatment, as it can potentiate the drug's effects, posing a risk. Grapefruit and its juice may interact adversely, potentially resulting in undesirable side effects; therefore, their consumption should be avoided. Increased sun sensitivity is a possibility with Dulogablin-NT Tablet use; minimize sun exposure and utilize protective clothing and sunscreen during daylight hours.
Routine check-ups with your physician are recommended following the commencement of Dulogablin-NT Tablet therapy. Seek immediate medical attention if your symptoms persist despite adhering to the prescribed Dulogablin-NT Tablet dosage, or if you experience adverse effects impacting your daily life.
Retain the tablets within their original packaging until ready for use. Maintain storage in a cool, dry environment. Keep the medication out of the view and reach of children. Proper disposal methods should be followed for unused medication to prevent accidental ingestion by children, pets, or others.
3,018 People bought this recently
Dulogablin-NT Tablet
238
MRP 290
17% off